1st Quarter - Report

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Period 1st Quarter 2014 Filed Apr 21, 2014 Signed by Brent DelMonte, Vice President for Federal Government Relations

Official filing
Firm
BIOTECHNOLOGY INNOVATION ORGANIZATION
Client
BIOTECHNOLOGY INNOVATION ORGANIZATION
Income
—
Expenses
$1,990,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

15 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Review and Labeling of Food Derived From Biotechnology House Energy and Commerce Discussion Draft U.S. Government PolicyEPA Regulations on Agricultural Biotechnology Efficient Science-Based Review of Biotech Products Herbicide Label Changes Insect Resistance Management Department of Interior, Environment, and Related Agencies Appropriations Act for FY 2015 Genetically Engineered (GE) Animals Labeling Agriculture, Rural Development, FDA, and Related Appropriations Act for 2015 FDA Approval H.R. 3547: Consolidated Appropriations Act for FY 2014 Funding for USDA H.R. 3547: Consolidated Appropriations Act for FY 2014 Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Foreign Agricultural Biotechnology Laws and Regulations Asynchrony of International Approvals China Biotechnology Regulations Korea Biotechnology Regulations Funding for Biotechnology Research and Development Programs at the Agency for International Development and Department of State H.R. 3547: Consolidated Appropriations Act for FY 2014 Biomass Programs Reauthorization of Biomass Crop Assistance Program Reauthorization of Biomass R&D Program S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 USDA/APHIS Agricultural Biotechnology Regulations Efficient Science-Based Review of Biotech Products USDA Decision on GE Crops Environmental Impact Statement Coexistence of Production Systems Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Trans Pacific Partnership Sanitary and Phytosanitary Issues Transatlantic Trade and Investment Partnership Ag-Biotech Issues

LobbyistCovered position, as disclosed
MATT CARR —
BRENT ALAN DELMONTE —
TOM DILENGE —
DAVID EDWARDS —
CATHLEEN ENRIGHT —
TRACEY LATURNER —
ERICK LUTT —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —
ANNA KATHERINE WEINSTEIN —
DERRICK M WHITE —

Contacted: U.S. Trade Representative (USTR); Natl Security Council (NSC); Federal Trade Commission (FTC); SENATE; Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Office of Management & Budget (OMB); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA)

Bills named: H.R. 1947 (113th), S. 954 (113th), H.R. 2642 (113th), H.R. 3547 (113th)

Consumer Issues/Safety/Products CSP

Funding for FDA Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014Genetically Engineered (GE) Animals Labeling Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2015 FDA Approval H.R. 3547: Consolidated Appropriations Act for FY 2014 Review and Labeling of Food Derived From Biotechnology House Energy and Commerce Discussion Draft U.S. Government Policy Drug Evaluation and Review Special Medical Use/Limited Population Drug Implementation of the FDA Safety and Innovation Act H.R. 3742: Antibiotic Development to Advance Patient Treatment Act of 2013 FDA Proposed Rule on Changes to Drug Labeling Biosimilars Naming Biosimilar User Fee Act Implementation Interchangeability and Pharmacy Substitution Colombia Biologics Regulations Drug Manufacturing, Quality & Distribution Implementation of H.R. 3204: The Drug Quality and Security Act USDA/APHIS Agricultural Biotechnology Regulations Efficient Science-Based Review of Biotech Products USDA Decision on GE Crops Environmental Impact Statement Coexistence of Production Systems Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Sunshine Act Implementation

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
TOM DILENGE —
DAVID EDWARDS —
ANDREW EMMETT —
CATHLEEN ENRIGHT —
ELIZABETH CARTIER ESHAM —
JEANNE HAGGERTY —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —
JEFFREY PETERS New —
SARA RADCLIFFE —
MATTHEW SCHUMAKER —
ANNA KATHERINE WEINSTEIN —
DERRICK M WHITE —

Contacted: Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); SENATE; Federal Trade Commission (FTC); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC)

Bills named: H.R. 3742 (113th), H.R. 3204 (113th), H.R. 3547 (113th)

Animals ANI

Genetically Engineered (GE) Animals Labeling Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2015 FDA ApprovalGenetically Engineered (GE) Animals Cont... H.R. 3547: Consolidated Appropriations Act for FY 2014

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
DAVID EDWARDS —
CATHLEEN ENRIGHT —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
ANNA KATHERINE WEINSTEIN —
DERRICK M WHITE —

Contacted: Natl Security Council (NSC); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Environmental Protection Agency (EPA)

Bills named: H.R. 3547 (113th)

Fuel/Gas/Oil FUE

Funding for Biomass Crop Assistance Program Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Biofuels Accelerated Depreciation Extension Production Tax Credit Extension Renewable Fuel Standard H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Biorefineries Reauthorization of Biorefinery Assistance Program HR 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Renewable Chemicals/Bio-based Products New Production Tax Credit for Renewable Chemicals Reauthorization of USDA Bio-Preferred Program Bonus Depreciation for Renewable Chemical Facilities S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act H.R. 2642: Agricultural Act of 2014 (Farm Bill) H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) Biomass Programs Reauthorization of Biomass R&D Program Reauthorization of Biomass Crop Assistance Program H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Energy Basic Research Funding H.R. 3547: Consolidated Appropriations Act for FY 2014 Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Funding for Renewable Chemicals/Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2015 H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Funding for Biofuels Department of Defense Funding of Advanced Biofuels Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Department of Defense Appropriations Act for FY 2015 Department of the Interior, Environment, and Related Agencies Appropriations for FY 2015 S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) H.R. 3547: Consolidated Appropriations Act for FY 2014 H.R. 2642: Agricultural Act of 2014 (Farm Bill)Funding for Biorefineries S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill)

LobbyistCovered position, as disclosed
MATT CARR —
BRENT ALAN DELMONTE —
CHARLES H FRITTS —
TRACEY LATURNER —
ERICK LUTT —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: Natl Institutes of Health (NIH); Securities & Exchange Commission (SEC); Federal Trade Commission (FTC); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Natl Security Council (NSC); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO)

Bills named: H.R. 3084 (113th), H.R. 2642 (113th), H.R. 3547 (113th), H.R. 1947 (113th), S. 954 (113th), S. 1267 (113th)

Budget/Appropriations BUD

Funding for FDA Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014Funding for USDA H.R. 3547: Consolidated Appropriations Act for FY 2014 Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014 Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014 Funding for Biomass Crop Assistance Program Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Sequestration of PDUFA Fees HR 2725: Food and Drug Administration Safety over Sequestration Act of 2013 S. 1413: FDA User Fee Protection Act H.R. 3547: Consolidated Appropriations Act for FY 2014 Energy Basic Research Funding Energy and Water Development and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014 Funding for Renewable Chemicals/Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Funding for Biofuels Department of Defense Funding of Advanced Biofuels Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Department of Defense Appropriations Act for FY 2015 S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Agriculture, Rural Development, FDA, and Related Agencies Appropriations for FY 2015 Department of the Interior, Environment, and Related Agencies Appropriations for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014 Funding for Biorefineries S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Funding for Biotechnology Research and Development Programs and the Agency for International Development and Department of State H.R. 3547: Consolidated Appropriations Act for FY 2014

LobbyistCovered position, as disclosed
PHYLLIS ARTHUR —
KELLY CAPPIO —
MATT CARR —
BRENT ALAN DELMONTE —
DAVID EDWARDS —
ANDREW EMMETT —
JEANNE HAGGERTY —
A. CATHARINE HARRIS —
TRACEY LATURNER —
ERICK LUTT —
DANA MAURICE O'BRIEN —
SARA RADCLIFFE —
MATTHEW SCHUMAKER —
ANNA KATHERINE WEINSTEIN —
DERRICK M WHITE —

Contacted: Natl Security Council (NSC); Office of Science & Technology Policy (OSTP); Federal Trade Commission (FTC); SENATE; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR)

Bills named: H.R. 2642 (113th), H.R. 2725 (113th), S. 954 (113th), H.R. 3547 (113th), S. 1413 (113th), H.R. 1947 (113th)

Energy/Nuclear ENG

Funding for Biomass Crop Assistance Program Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Biofuels Accelerated Depreciation Extension Production Tax Credit Extension Renewable Fuel Standard H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Biorefineries Reauthorization of Biorefinery Assistance Program HR 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Renewable Chemicals/Bio-based Products New Production Tax Credit for Renewable Chemicals Reauthorization of USDA Bio-Preferred Program Bonus Depreciation for Renewable Chemical Facilities S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act H.R. 2642: Agricultural Act of 2014 (Farm Bill) H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) Biomass Programs Reauthorization of Biomass R&D Program Reauthorization of Biomass Crop Assistance Program H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Energy Basic Research Funding H.R. 3547: Consolidated Appropriations Act for FY 2014 Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Funding for Renewable Chemicals/Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2015 H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill) Funding for Biofuels Department of Defense Funding of Advanced Biofuels Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Department of Defense Appropriations Act for FY 2015 Department of the Interior, Environment, and Related Agencies Appropriations for FY 2015 S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) H.R. 3547: Consolidated Appropriations Act for FY 2014 H.R. 2642: Agricultural Act of 2014 (Farm Bill)Funding for Biorefineries S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill) H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill) H.R. 2642: Agricultural Act of 2014 (Farm Bill)

LobbyistCovered position, as disclosed
MATT CARR —
BRENT ALAN DELMONTE —
CHARLES H FRITTS —
TRACEY LATURNER —
ERICK LUTT —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: Office of Management & Budget (OMB); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); SENATE; Federal Trade Commission (FTC); Natl Security Council (NSC); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA)

Bills named: H.R. 3084 (113th), S. 1267 (113th), H.R. 1947 (113th), H.R. 2642 (113th), S. 954 (113th), H.R. 3547 (113th)

Food Industry (safety, labeling, etc.) FOO

Review and Labeling of Food Derived From Biotechnology House Energy and Commerce Discussion Draft U.S. Government PolicyGenetically Engineered (GE) Animals Labeling Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2015 FDA Approval H.R. 3547: Consolidated Appropriations Act for FY 2014

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
TOM DILENGE —
DAVID EDWARDS —
CATHLEEN ENRIGHT —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —
ANNA KATHERINE WEINSTEIN —
DERRICK M WHITE —

Contacted: Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Natl Security Council (NSC); Office of Science & Technology Policy (OSTP); Securities & Exchange Commission (SEC)

Bills named: H.R. 3547 (113th)

Homeland Security HOM

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014

LobbyistCovered position, as disclosed
PHYLLIS ARTHUR —
KELLY CAPPIO —
BRENT ALAN DELMONTE —
TRACEY LATURNER —
SARA RADCLIFFE —
ANNA KATHERINE WEINSTEIN —
DERRICK M WHITE —

Contacted: Natl Security Council (NSC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE; Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR)

Bills named: H.R. 3547 (113th)

Trade (domestic/foreign) TRD

Trade Promotion Authority H.R. 3830/S. 1900: Bipartisan Congressional Trade Priorities Act of 2014Intellectual Property International Enforcement Compulsory Licensing Foreign Agricultural Biotechnology Laws and Regulations Asynchrony of International Approvals China Biotechnology Regulations Korea Biotechnology Regulations Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Regulatory Transparency Sanitary and Phytosanitary Issues Transatlantic Trade and Investment Partnership Intellectual Property Issues Regulatory Harmonization Ag-Biotech Issues Reimbursement Transparency Biosimilars Colombia Biologics Regulations World Trade Organization Special 301 Submissions Clinical Trial Data Sharing and Disclosure EU Policies

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
BRENT ALAN DELMONTE —
TOM DILENGE —
ANDREW EMMETT —
CHARLES H FRITTS —
JEANNE HAGGERTY —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —
ANNA KATHERINE WEINSTEIN —

Contacted: Securities & Exchange Commission (SEC); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); Natl Security Council (NSC); U.S. Trade Representative (USTR)

Bills named: S. 1900 (113th), H.R. 3830 (113th)

Taxation/Internal Revenue Code TAX

Biofuels Accelerated Depreciation Extension Production Tax Credit ExtensionRenewable Chemicals/Bio-based Products New Production Tax Credit for Renewable Chemicals S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act Bonus Depreciation for Renewable Chemical Facilities Research & Development Tax Credit Reforms Extension Permanency The Start-up Innovation Credit Act (Senator Coons Discussion Draft) The Innovative Research and Competitiveness Act (Senator Carper Discussion Draft) Capital Formation Investment Incentives Reform of Passive Loss Rules Reform of Net Operating Loss Rules Reform of Capital Gains Rules S. 1658: The Start-up Jobs and Innovation Act House Ways and Means Committee Discussion Draft (Rep. Camp) Tax Reform House Ways and Means Committee Discussion Draft (Rep. Camp) Orphan Drug Act Tax Credit Controlled Foreign Corporation Look-Through Rule Extension

LobbyistCovered position, as disclosed
MATT CARR —
CHARLES CRAIN —
BRENT ALAN DELMONTE —
TOM DILENGE —
CHARLES H FRITTS —
ERICK LUTT —
SHELLY MUI-LIPNIK —
MATTHEW SCHUMAKER —
RINA SINGH —

Contacted: U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); Natl Security Council (NSC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Federal Trade Commission (FTC); Securities & Exchange Commission (SEC)

Bills named: S. 1267 (113th), S. 1658 (113th), H.R. 3084 (113th)

Copyright/Patent/Trademark CPT

Genetic Resource Patent Disclosure Requirement World Intellectual Property OrganizationPatent Reform S. 866: Patent Quality Improvement Act of 2013 S. 1720: Patent Transparency and Improvements Act of 2013 H.R. 3309: The Innovation Act of 2013 S. 1013: Patent Abuse Reduction Act of 2013 FTC Regulation of Patent Demand Letters (Senator McCaskill Discussion Draft) World Trade Organization Special 301 Submissions Intellectual Property International Enforcement Compulsory Licensing TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership Intellectual Property Issues Drug Repurposing H.R. 4287/2150: Independent Innovator and Repurposing Act

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
BRENT ALAN DELMONTE —
TOM DILENGE —
CHARLES H FRITTS —
JEANNE HAGGERTY —
HANSJORG SAUER —
MATTHEW SCHUMAKER —
ANNA KATHERINE WEINSTEIN —
DERRICK M WHITE —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Federal Trade Commission (FTC); Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; Natl Security Council (NSC); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR)

Bills named: H.R. 3309 (113th), S. 1720 (113th), S. 866 (113th), H.R. 4287 (113th), S. 1013 (113th)

Health Issues HCR

Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014Biosimilars Naming Biosimilar User Fee Act Implementation Interchangeability and Pharmacy Substitution Colombia Biologics Regulations Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014 Vaccine Access/Financing Vaccine Injury Compensation Program Adult Immunization (Senate Discussion Draft) 340B Drug Pricing Program Program Implementation & Oversight Implementation of Affordable Care Act Department of Labor, HHS, Education and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014 Funding for FDA Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014 Reimbursement for Innovative Products Medicare Part D Prescription Drug Program CMS Proposed Rule on Protected Classes Medicare Part B Physician-Administered Products H.R. 1416: Cancer Patient Protection Act of 2013 National Center for Advancing Translational Science (NCATS) Program Implementation Sequestration of PDUFA Fees HR 2725: Food and Drug Administration Safety over Sequestration Act of 2013 S. 1413: FDA User Fee Protection Act H.R. 3547: Consolidated Appropriations Act for FY 2014 Drug Repurposing H.R. 4287/2150: Independent Innovator and Repurposing Act Transatlantic Trade and Investment Partnership Reimbursement Transparency Intellectual Property Issues Regulatory HarmonizationTransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Regulatory Transparency Drug Evaluation and Review Special Medical Use/Limited Population Drug H.R. 3742: Antibiotic Development to Advance Patient Treatment Act of 2013 Implementation of the FDA Safety and Innovation Act FDA Proposed Rule on Changes to Drug Labeling Orphan Drug Act Tax Credit Drug Manufacturing, Quality & Distribution Implementation of H.R. 3204: The Drug Quality and Security Act Sunshine Act Implementation Medicare Physician Payment Sustainable Growth Rate Formula HR 4302: Protecting Access to Medicare Act of 2014 S. 2110: Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 S. 2000: SGR Repeal and Medicare Provider Payment Modernization Act of 2014 S. 2122: Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 Clinical Trial Data Sharing and Disclosure EU Policies

LobbyistCovered position, as disclosed
PHYLLIS ARTHUR —
KELLY CAPPIO —
CHARLES CRAIN —
BRENT ALAN DELMONTE —
TOM DILENGE —
ANDREW EMMETT —
ELIZABETH CARTIER ESHAM —
CHARLES H FRITTS —
JEANNE HAGGERTY —
A. CATHARINE HARRIS —
TRACEY LATURNER —
SHELLY MUI-LIPNIK —
JEFFREY PETERS New —
SARA RADCLIFFE —
MATTHEW SCHUMAKER —
LAUREL TODD —
ANNA KATHERINE WEINSTEIN —
DERRICK M WHITE —

Contacted: Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); Office of Management & Budget (OMB); SENATE; Natl Security Council (NSC); Federal Trade Commission (FTC); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); U.S. Trade Representative (USTR)

Bills named: H.R. 3204 (113th), H.R. 2725 (113th), S. 2110 (113th), H.R. 1416 (113th), H.R. 3547 (113th), S. 1413 (113th), H.R. 3742 (113th), S. 2122 (113th), H.R. 4302 (113th), H.R. 4287 (113th), S. 2000 (113th)

Small Business SMB

Capital Market Enhancements H.R. 3623: Improving Access to Capital for Emerging Growth Companies ActSarbanes Oxley Section 404 (b) Mandatory Audit Firm Rotation H.R. 1564/S. 1526: The Audit Integrity and Job Protection Act Capital Formation Investment Incentives Reform of Passive Loss Rules Reform of Net Operating Loss Rules Reform of Capital Gains Rules S. 1658: The Start-up Jobs and Innovation Act Reform of SEC Regulation D Implementation of Jumpstart Our Business Start-ups (JOBS) Act Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions H.R. 2629: The Fostering Innovation Act XBRL Exemption for Small Public Companies H.R. 4164: Small Company Disclosure Simplification Act Stock Exchange Tick Size H.R. 3488: The Small Cap Liquidity Reform Act

LobbyistCovered position, as disclosed
CHARLES CRAIN —
BRENT ALAN DELMONTE —
TOM DILENGE —
ELIZABETH CARTIER ESHAM —
CHARLES H FRITTS —
SHELLY MUI-LIPNIK —

Contacted: Office of Management & Budget (OMB); Natl Security Council (NSC); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Federal Trade Commission (FTC); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP)

Bills named: S. 1526 (113th), H.R. 4164 (113th), H.R. 3623 (113th), S. 1658 (113th), H.R. 2629 (113th), H.R. 1564 (113th), H.R. 3488 (113th)

Medicare/Medicaid MMM

Independent Payment Advisory BoardReimbursement for Innovative Products Medicare Part D Prescription Drug Program CMS Proposed Rule on Protected Classes Medicare Part B Physician-Administered Products H.R. 1416: Cancer Patient Protection Act of 2013 Medicare Physician Payment Sustainable Growth Rate Formula HR 4302: Protecting Access to Medicare Act of 2014 S. 2110: Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 S. 2000: SGR Repeal and Medicare Provider Payment Modernization Act of 2014 S. 2122: Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
JEANNE HAGGERTY —
A. CATHARINE HARRIS —
MATTHEW SCHUMAKER —
LAUREL TODD —
ANNA KATHERINE WEINSTEIN —
DERRICK M WHITE —

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); Natl Security Council (NSC); Environmental Protection Agency (EPA); SENATE; Securities & Exchange Commission (SEC); Federal Trade Commission (FTC); Food & Drug Administration (FDA); U.S. Trade Representative (USTR)

Bills named: S. 2000 (113th), H.R. 1416 (113th), S. 2110 (113th), H.R. 4302 (113th), S. 2122 (113th)

Medical/Disease Research/Clinical Labs MED

Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 H.R. 3547: Consolidated Appropriations Act for FY 2014 National Center for Advancing Translational Science (NCATS) Program Implementation

LobbyistCovered position, as disclosed
PHYLLIS ARTHUR —
KELLY CAPPIO —
BRENT ALAN DELMONTE —
ELIZABETH CARTIER ESHAM —
TRACEY LATURNER —
SARA RADCLIFFE —
ANNA KATHERINE WEINSTEIN —
DERRICK M WHITE —

Contacted: Office of Science & Technology Policy (OSTP); SENATE; U.S. Trade Representative (USTR); Natl Security Council (NSC); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Federal Trade Commission (FTC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3547 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.